These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 32059422)

  • 41. microRNAs and Neurodegenerative Diseases.
    Qiu L; Tan EK; Zeng L
    Adv Exp Med Biol; 2015; 888():85-105. PubMed ID: 26663180
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Comprehensive Review of Therapeutic Compounds from Plants for Neurodegenerative Diseases.
    P DS; K A; S M; Gopinath SCB; Raman P
    Curr Med Chem; 2024 Feb; ():. PubMed ID: 38367263
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Salivary markers of oxidative stress in oral diseases.
    Tóthová L; Kamodyová N; Červenka T; Celec P
    Front Cell Infect Microbiol; 2015; 5():73. PubMed ID: 26539412
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Role of Reactive Oxygen Species in the Pathogenesis of Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease: A Mini Review.
    Manoharan S; Guillemin GJ; Abiramasundari RS; Essa MM; Akbar M; Akbar MD
    Oxid Med Cell Longev; 2016; 2016():8590578. PubMed ID: 28116038
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Linking mitochondrial dysfunction, metabolic syndrome and stress signaling in Neurodegeneration.
    Jha SK; Jha NK; Kumar D; Ambasta RK; Kumar P
    Biochim Biophys Acta Mol Basis Dis; 2017 May; 1863(5):1132-1146. PubMed ID: 27345267
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Role of Oxidative Stress in Neurodegenerative Diseases.
    Kim GH; Kim JE; Rhie SJ; Yoon S
    Exp Neurobiol; 2015 Dec; 24(4):325-40. PubMed ID: 26713080
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ambulatory Activity Components Deteriorate Differently across Neurodegenerative Diseases: A Cross-Sectional Sensor-Based Study.
    Klenk J; Srulijes K; Schatton C; Schwickert L; Maetzler W; Becker C; Synofzik M
    Neurodegener Dis; 2016; 16(5-6):317-23. PubMed ID: 27197840
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antioxidants as treatment for neurodegenerative disorders.
    Moosmann B; Behl C
    Expert Opin Investig Drugs; 2002 Oct; 11(10):1407-35. PubMed ID: 12387703
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ion Channels in Neurological Disorders.
    Kumar P; Kumar D; Jha SK; Jha NK; Ambasta RK
    Adv Protein Chem Struct Biol; 2016; 103():97-136. PubMed ID: 26920688
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MiR-124 and the Underlying Therapeutic Promise of Neurodegenerative Disorders.
    Han D; Dong X; Zheng D; Nao J
    Front Pharmacol; 2019; 10():1555. PubMed ID: 32009959
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of Salivary Biomarkers in Oral Cancer Detection.
    Khurshid Z; Zafar MS; Khan RS; Najeeb S; Slowey PD; Rehman IU
    Adv Clin Chem; 2018; 86():23-70. PubMed ID: 30144841
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Underlying Role of Oxidative Stress in Neurodegeneration: A Mechanistic Review.
    Yaribeygi H; Panahi Y; Javadi B; Sahebkar A
    CNS Neurol Disord Drug Targets; 2018; 17(3):207-215. PubMed ID: 29692267
    [TBL] [Abstract][Full Text] [Related]  

  • 53. NDDRF: A risk factor knowledgebase for personalized prevention of neurodegenerative diseases.
    Bi C; Zhou S; Liu X; Zhu Y; Yu J; Zhang X; Shi M; Wu R; He H; Zhan C; Lin Y; Shen B
    J Adv Res; 2022 Sep; 40():223-231. PubMed ID: 36100329
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Psychopharmacological neuroprotection in neurodegenerative diseases, part III: criteria-based assessment: a report of the ANPA committee on research.
    Lauterbach EC; Mendez MF
    J Neuropsychiatry Clin Neurosci; 2011; 23(3):242-60. PubMed ID: 21948886
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of Natural Compounds on Neurodegenerative Disorders: From Preclinical to Pharmacotherapeutics.
    Sharifi-Rad M; Lankatillake C; Dias DA; Docea AO; Mahomoodally MF; Lobine D; Chazot PL; Kurt B; Tumer TB; Moreira AC; Sharopov F; Martorell M; Martins N; Cho WC; Calina D; Sharifi-Rad J
    J Clin Med; 2020 Apr; 9(4):. PubMed ID: 32276438
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alzheimer's Disease and Parkinson's Disease: A Review of Current Treatment Adopting a Nanotechnology Approach.
    Trompetero A; Gordillo A; Del Pilar MC; Cristina VM; Bustos Cruz RH
    Curr Pharm Des; 2018; 24(1):22-45. PubMed ID: 28847307
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Salivary Antioxidant Barrier, Redox Status, and Oxidative Damage to Proteins and Lipids in Healthy Children, Adults, and the Elderly.
    Maciejczyk M; Zalewska A; Ładny JR
    Oxid Med Cell Longev; 2019; 2019():4393460. PubMed ID: 31885792
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Avocado as a Major Dietary Source of Antioxidants and Its Preventive Role in Neurodegenerative Diseases.
    Ameer K
    Adv Neurobiol; 2016; 12():337-54. PubMed ID: 27651262
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mitochondria and neurodegenerative diseases: Special issue of BMB Reports in 2020.
    Chung KC
    BMB Rep; 2020 Jan; 53(1):1-2. PubMed ID: 31865963
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Autophagy and apoptosis dysfunction in neurodegenerative disorders.
    Ghavami S; Shojaei S; Yeganeh B; Ande SR; Jangamreddy JR; Mehrpour M; Christoffersson J; Chaabane W; Moghadam AR; Kashani HH; Hashemi M; Owji AA; Łos MJ
    Prog Neurobiol; 2014 Jan; 112():24-49. PubMed ID: 24211851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.